Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T22977 | Target Info | |||
Target Name | Superoxide dismutase Cu-Zn (SOD Cu-Zn) | ||||
Synonyms | hSod1; Superoxide dismutase [Cu-Zn]; Superoxide dismutase 1; Superoxide dismutase | ||||
Target Type | Clinical trial Target | ||||
Gene Name | SOD1 | ||||
Biochemical Class | Superoxide dismutase/reductase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Tetrasulfane | Ligand Info | |||
Canonical SMILES | SSSS | ||||
InChI | 1S/H2S4/c1-3-4-2/h1-2H | ||||
InChIKey | IKRMQEUTISXXQP-UHFFFAOYSA-N | ||||
PubChem Compound ID | 82836 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 5YUL Native Structure of hSOD1 in P6322 space group | ||||||
Method | X-ray diffraction | Resolution | 1.90 Å | Mutation | No | [1] |
PDB Sequence |
MATKAVCVLK
9 GDGPVQGIIN19 FEQKESNGPV29 KVWGSIKGLT39 EGLHGFHVHE49 FGDNTAGCTS 59 AGPHFNPLSR69 KHGGPKDEER79 HVGDLGNVTA89 DKDGVADVSI99 EDSVISLSGD 109 HCIIGRTLVV119 HEKADDLGKG129 GNEESTKTGN139 AGSRLACGVI149 GIAQ |
|||||
|
||||||
PDB ID: 6A9O Rational discovery of a SOD1 tryptophan oxidation inhibitor with therapeutic potential for amyotrophic lateral sclerosis | ||||||
Method | X-ray diffraction | Resolution | 2.50 Å | Mutation | No | [2] |
PDB Sequence |
MATKAVCVLK
9 GDGPVQGIIN19 FEQKESNGPV29 KVWGSIKGLT39 EGLHGFHVHE49 FGDNTAGCTS 59 AGPHFNPLSR69 KHGGPKDEER79 HVGDLGNVTA89 DKDGVADVSI99 EDSVISLSGD 109 HCIIGRTLVV119 HEKADDLGKG129 GNEESTKTGN139 AGSRLACGVI149 GIAQ |
|||||
|
||||||
PDB ID: 5YTU Structure of human SOD1 complexed with isoproteranol in C2221 space group | ||||||
Method | X-ray diffraction | Resolution | 1.90 Å | Mutation | No | [1] |
PDB Sequence |
MATKAVCVLK
9 GDGPVQGIIN19 FEQKESNGPV29 KVWGSIKGLT39 EGLHGFHVHE49 FGDNTAGCTS 59 AGPHFNPLSR69 KHGGPKDEER79 HVGDLGNVTA89 DKDGVADVSI99 EDSVISLSGD 109 HCIIGRTLVV119 HEKADDLGKG129 GNEESTKTGN139 AGSRLACGVI149 GIAQ |
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Assessment of ligand binding at a site relevant to SOD1 oxidation and aggregation. FEBS Lett. 2018 May;592(10):1725-1737. | ||||
REF 2 | Rational discovery of a SOD1 tryptophan oxidation inhibitor with therapeutic potential for amyotrophic lateral sclerosis. J Biomol Struct Dyn. 2019 Sep;37(15):3936-3946. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.